Information  X 
Enter a valid email address

Telefonica Emisiones (38KE)

  Print   

Wednesday 31 October, 2018

Telefonica Emisiones

Prospectus Supplement. _EMTN_31 October 2018

RNS Number : 9253F
Telefonica Emisiones S.A.U.
31 October 2018
 

Publication of Supplementary Listing Prospectus

The following Supplementary Listing Prospectus, which supplements the Base Prospectus dated 19 June 2018, has been approved by the UK Listing Authority and is available for viewing:

Supplement dated 31 October 2018 to the Base Prospectus dated 19 June 2018 relating to the Telefónica Emisiones S.A.U. €40,000,000,000 Programme for the Issuance of Debt Instruments guaranteed by Telefónica, S.A.

 

To view the full document, please paste the following URL into the address bar of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/9253F_1-2018-10-31.pdf

 

For further information, please contact

Investors Relations
Telefónica, S.A.

Distrito Telefonica - Edificio Central Pl 2ª

C/Ronda de la Comunicación s/n

28050 Madrid

Spain
Tel.: +34 91 482 8700

 

[email protected]

 

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirement. 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
PSPEFLFXVBFEFBD

a d v e r t i s e m e n t